AgriLabs, St. Joseph, Mo., now markets Mycomune R

RESPIRATORY DISEASE PREVENTION--AgriLabs, St. Joseph, Mo., now markets Mycomune R, a vaccine to prevent respiratory disease in calves caused by Mycoplasma bovis. Mycomune R was developed by CEVA Biomune, Lenexa, Kan., and allows producers to administer the vaccine to calves at a much younger age. Mycomune R contains the same four highly immunogenic protective strains found in the current Mycomune, which has been available for three years and is the only USDA-approved vaccine for the prevention and control of mastitis caused by Mycoplasma bovis in mature cows. Mycomune R offers a significant advantage of vaccinating calves early so they can develop immunity before being commingled with other cattle, which usually occurs by 45 to 60 days of age. Additionally, Mycomune R has a withdrawal period of only 21 days, versus 60 days for competitive products. For more information, call 800-542-8916, or visit www.AgriLabs.com.

11/17/08
None\4-C

Date: 11/11/08

1

Click for related articles

Wyobraska cattle sales report
Presho livestock sales report
Lexington livestock sales report
Clovis livestock auction report

1 article 2008- 47 - NP8AgriLabsdctjml.cfm

Article: AgriLabs, St. Joseph, Mo., now markets Mycomune R Add Your Comment To post a comment on this story, enter your screen name and email address then click "Add Comment." Your email address will not be displayed. 107 Recommend | 0 Comments

---

	Web hpj.com

Copyright/Privacy
Copyright 1995-2010.  High Plains Publishers, Inc.  All rights reserved.  Any republishing of these pages, including electronic reproduction of the editorial archives or classified advertising, is strictly prohibited. If you have questions or comments you can reach us at High Plains Journal 1500 E. Wyatt Earp Blvd., P.O. Box 760, Dodge City, KS 67801 or call 1-800-452-7171. Email: webmaster@hpj.com